Curaleaf Holdings M&A Deal with Aurora Cannabis Inc.
Curaleaf Holdings announced it has received all required competition law clearances from regulators in Germany and Canada for its proposed acquisition of Aurora Cannabis Inc. The company's enhanced premium bid to acquire all outstanding shares of Aurora remains open until December 4, 2026, as it competes against a rival proposal from Organigram.
Curaleaf Holdings M&A Deal with Aurora Cannabis Inc.
Curaleaf Holdings issued a statement reaffirming its outstanding premium bid to acquire all common shares of Aurora Cannabis, despite Aurora announcing an alternative transaction with Organigram Global Inc. Curaleaf argues its offer provides superior value and synergies compared to the Organigram proposal and criticized the Aurora board for refusing to engage directly or grant due diligence access.
Curaleaf Holdings M&A Deal with Boone Town Provisions
Curaleaf Holdings has acquired an equity stake and certain operating rights in Boone Town Provisions, a high-performing cannabis dispensary in Boonton, New Jersey. The acquisition expands Curaleaf's retail footprint to four dispensaries in New Jersey and 191 nationwide. The transaction is expected to be immediately accretive to the company's New Jersey operations.
Counterparty
Boone Town Provisions
“Boone Town Provisions is one of the top-performing dispensaries in New Jersey. We have acquired our interest in the dispensary at an attractive valuation that aligns with our disciplined approach to capital allocation. The acquisition strengthens our position in New Jersey, allows us to increase our vertical position, adds a proven, high-performing location to our retail footprint, and expands access to our brands for more customers in the state.”
Curaleaf Holdings M&A Deal with Aurora Cannabis Inc.
Curaleaf Holdings issued a status update regarding its hostile takeover bid for Aurora Cannabis, responding to a ruling by the Alberta Securities Commission. Curaleaf is advocating for its enhanced offer, which it values at approximately $5.00 per share (an 86% premium), while criticizing Aurora's board for dilutive share issuances and for excluding Curaleaf from the strategic review process.
Counterparty
Aurora Cannabis Inc.
“Aurora would like shareholders to believe the ASC's ruling changes the fundamental debate. It does not. The questions confronting Aurora shareholders remain the same today as they were yesterday: why did Aurora issue shares under an ATM for less than the original offer price after Curaleaf indicated a bid was coming, why is a now 86% premium offer being dismissed as inadequate and a discounted offer, why is Curaleaf continuing to be excluded from customary diligence when others aren't, and why is the Board asking shareholders to reject a proposal before allowing a fully informed process to play out?”
Boris Jordan, Chairman of the Board and Chief Executive Officer of Curaleaf
Curaleaf Holdings M&A Deal with Aurora Cannabis Inc.
Curaleaf Holdings, Inc. responded to Aurora Cannabis Inc.'s rejection of its enhanced acquisition proposal, challenging the Aurora Board's refusal to grant due diligence access. Curaleaf noted its offer represents an 86% premium to Aurora's unaffected 30-day VWAP and criticized Aurora for providing diligence access to other unnamed parties while obstructing Curaleaf's binding offer.
Curaleaf Holdings M&A Deal with Aurora Cannabis Inc.
Curaleaf Holdings, Inc. has filed a formal Notice of Variation to increase its offer to acquire all outstanding shares of Aurora Cannabis Inc. The enhanced offer provides total implied consideration of US$5.00 per share, consisting of 0.4013 Curaleaf shares and US$1.00 in cash, representing an 86% premium to Aurora's unaffected share price.
Curaleaf Holdings M&A Deal with Aurora Cannabis Inc.
Curaleaf Holdings, Inc. has filed a Notice of Variation to its existing tender offer to acquire all outstanding shares of Aurora Cannabis Inc. The amended offer increases the consideration to US$1.00 in cash plus 0.4013 Curaleaf subordinate voting shares per Aurora share and extends the expiry date to December 4, 2026.
Curaleaf Holdings, Inc. has launched a hostile takeover bid for Aurora, offering a combination of 0.3463 Curaleaf shares and $0.75 in cash per Aurora share, implying a total offer price of $4.00. The deal represents a 45% premium over Aurora's 30-day VWAP and aims to create a global cannabis leader with over $1.5 billion in annual revenue and operations across 17 countries.
Curaleaf Holdings M&A Deal with Aurora Cannabis Inc.
Curaleaf Holdings, Inc. issued a letter to shareholders of Aurora Cannabis Inc. urging them to accept its acquisition offer, which represents a 45% premium over Aurora's 30-day VWAP. The proposed combination would create a global cannabis leader with operations in 17 countries and approximately $1.5 billion in combined LTM revenue.
Curaleaf Holdings has filed an application with the Alberta Securities Commission to halt Aurora's at-the-market (ATM) share issuance program during Curaleaf's pending acquisition offer. Curaleaf argues that Aurora's continued share sales at prices below the $4.00 offer price are an abusive defensive tactic that has increased the deal's cost by over $11 million and diluted shareholders by approximately 11%.